United States Federal Circuit
BOEHRINGER INGELHEIM VETMEDICA, INC. v. SCHERING-PLOUGH CORP., 02-1026, 02-1027
District court correctly construed a claim relating to the process for growing and isolating the Porcine Reproductive Respiratory Syndrome virus. The jury's verdict for plaintiff on infringement under the doctrine of equivalents, and its verdict against defendant on its obviousness challenge, were well-supported by substantial evidence.
Appellate Information
- Decided 02/21/2003
- Published 02/21/2003
Judges
- CLEVENGER, Circuit Judge., Before MAYER, Chief Judge, CLEVENGER and RADER, Circuit Judges.
Court
- United States Federal Circuit
Counsel
- For Appellant:
- Jennifer Gordon,Orrick, Herrington & Sutcliffe LLP, of New York, NY, argued for plaintiff-cross appellant. With her on the brief were Scott D. Stimpson, John D. Garretson, and Todd L. Krause, Pennie & Edmonds LLP, of New York, NY. Of counsel on the brief were Robert P. Raymond, Boehringer Ingelheim Corporation, of Ridgefield, CT; and Jonathan A. Marshall, Weil Gotshal & Manges LLP, of New York, NY.
- For Appellees:
- William K. West, Jr., Howrey Simon Arnold & White, LLP, of Washington, DC, argued for defendants-appellants. With him on the brief were John W. Nields, Jr., Karen M. Lockwood, and Kevin G. Baer. Of counsel on the brief were John F. Hoffmann and Arthur Mann, Schering-Plough Corporation, of Kenilworth, NJ. Of counsel were Paul H. Kochanski and Sidney David, Lerner David, of Westfield, NJ.